Serotonin News and Research

Latest Serotonin News and Research

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

Scientists identify genome regions linked to migraine risk

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine.

3 Feb 2022

Psychedelic analogs show antidepressant-like activity in mice without causing hallucination

Analogs of drugs like psilocybin and LSD show antidepressant-like activity in mice without causing hallucination, researchers report.

27 Jan 2022

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

As researchers continue to seek effective treatment options for menopause symptoms as alternatives to proven pharmacologic solutions, a number of innovative therapies have been shown to improve symptoms.

27 Jan 2022

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

An interdisciplinary team of researchers from Europe analyzed the alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients.

26 Jan 2022

Estrogen-activated neurocircuit in females provide anti-obesity benefits

Seeking to better understand the key role the female hormone estrogen plays in maintaining energy balance and weight control, a group led by researchers at Baylor College of Medicine looked into estrogen interactions with specific brain regions that provide these anti-obesity benefits.

20 Jan 2022

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers are one step closer to developing a blood test that provides a simple biochemical hallmark for depression and reveals the efficacy of drug therapy in individual patients.

3 Jan 2022

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Diabetic neuropathy refers to nerve damage due to diabetes and it may lead to pain and numbness, most often in the hands and feet. To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy.

28 Dec 2021

Doctors advised to prescribe fewer antidepressants and for shorter periods of time

Doctors should prescribe fewer antidepressants and for shorter periods of time, because of the ongoing uncertainties about their effectiveness and the potential severity and durability of the withdrawal symptoms associated with them, suggests a review of the evidence on antidepressant use, published online in the Drug and Therapeutics Bulletin.

21 Dec 2021

Clinical drug research for the treatment of CNS and neurological disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.

29 Nov 2021

Researchers discover new link between diet, intestinal stem cells and disease

The intestine is essential for maintaining our energy balance and is a master at reacting quickly to changes in nutrition and nutrient balance.

21 Nov 2021

Genetically engineered bacteria can monitor health from within

That feeling in your gut? Well, it's in your head, but some of it does truly start in the gastrointestinal tract.

12 Nov 2021

Psychiatric drug prevents some of the most serious complications of COVID-19, study finds

Leonard Imbula of the Healthy Mind Lab at Washington University School of Medicine in St. Louis holds a bottle of fluvoxamine, a psychiatric drug that has been shown, in a pair of studies conducted on two continents, to be an effective treatment for people sick with COVID-19.

9 Nov 2021

Study identifies serotonin as a possible trigger of flare-ups in Crohn's disease

A new treatment may be on the horizon for people with a major form of inflammatory bowel disease (IBD) called Crohn's disease, after a McMaster University-led study identified serotonin as a possible trigger of flare-ups.

6 Nov 2021

Psychology professor secures $2.59 million NIH grant to study the brain mechanisms of addiction

A five-year, $2.59 million grant from the National Institutes of Health will allow a psychology professor at Binghamton University, State University of New York to study the mechanisms of addiction.

2 Nov 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.

29 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

Mothers pass on the legacy of stress exposure to future generations

A mother's response to stress can even influence her grandchildren. Biologists at the University of Iowa found that roundworm mothers subjected to heat stress passed, under certain conditions and through modifications to their genes, the legacy of that stress exposure not only to their offspring but even to their offspring's children.

13 Oct 2021

Accumulation of amyloid beta and reduction of serotonin may trigger late-life depression

Looking for ways to image the human brain for the earliest signs of aging and cognitive decline, Johns Hopkins Medicine researchers recently identified a pattern that links the accumulation of amyloid beta (Aβ) proteins (associated with cognitive decline later in life) with a reduction of serotonin, the brain chemical that improves mood.

7 Oct 2021

Serotonin News and Research

Latest Serotonin News and Research

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Scientists identify genome regions linked to migraine risk

Psychedelic analogs show antidepressant-like activity in mice without causing hallucination

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Estrogen-activated neurocircuit in females provide anti-obesity benefits

Researchers identify a biomarker in platelets that tracks the extent of depression

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Doctors advised to prescribe fewer antidepressants and for shorter periods of time

Clinical drug research for the treatment of CNS and neurological disorders

Researchers discover new link between diet, intestinal stem cells and disease

Genetically engineered bacteria can monitor health from within

Psychiatric drug prevents some of the most serious complications of COVID-19, study finds

Study identifies serotonin as a possible trigger of flare-ups in Crohn's disease

Psychology professor secures $2.59 million NIH grant to study the brain mechanisms of addiction

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

Mothers pass on the legacy of stress exposure to future generations

Accumulation of amyloid beta and reduction of serotonin may trigger late-life depression

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Serotonin News and Research

Latest Serotonin News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in